"Normal" on a blood test doesn't mean what most people think it means. The word was formally retired by the International Organization for Standardization in 2014 and replaced with "reference interval." The reason: "normal" was misleading patients and clinicians alike.
A reference interval represents the middle 95% of results from a reference population. By definition, 5% of healthy people fall outside it. That's a statistical artefact, not a clinical judgement. The reference population itself may include individuals with undiagnosed conditions. And the interval varies between laboratories, sometimes significantly.
This isn't a fringe observation. It comes from the RCPA and AACB, the bodies that set Australia's pathology standards. A 2017 study by Jones and Koetsier, published in Annals of Clinical Biochemistry, found that the same blood result could be flagged at one Australian laboratory and cleared at another. For sodium, the lower reference limit varied from 132 to 137 mmol/L across laboratories using identical analytical methods.
The same blood. The same machine. Different conclusions.
Understanding what a reference interval actually is changes how you read every blood test you'll ever receive. It's a framework, not a verdict.
How reference intervals are built
A reference interval is constructed by testing a large group of apparently healthy people, removing statistical outliers, and defining the range that captures 95% of results. This is a legitimate and useful statistical method. It identifies where most people sit. It does not identify where any individual person functions best.
Several features of this process are worth understanding.
The reference population is selected, not universal. Australian laboratories use a mix of locally derived and internationally adopted intervals. The people in the reference group are screened for obvious disease, but they may include individuals with subclinical conditions, undiagnosed deficiencies, or early-stage metabolic changes. The "healthy" population may not be as healthy as the label implies.
The 95% capture rate means that 2.5% of genuinely healthy people will fall below the lower limit and 2.5% above the upper limit. On a panel with twenty markers, pure statistics predict that a completely healthy person will have at least one result outside the reference interval. This does not mean something is wrong. It means the statistical tool has limitations that most result reports don't explain.
Intervals are population-level, not individual-level. Your body has its own set point for every marker. If your ferritin typically sits at 120 and drops to 35, it's still "in range" at most laboratories. But for your body, that's a 70% decline. The reference interval doesn't capture intra-individual variation because it wasn't designed to.
Where the gap matters most
For disease detection, reference intervals work well. A fasting glucose of 15 mmol/L is unambiguously abnormal. An HbA1c of 9% requires immediate attention. The standard panel excels at identifying pathology.
The gap appears in the subclinical range, the space between "you have a disease" and "everything is working well." Several markers illustrate this clearly.
Ferritin. Many Australian laboratories set the lower reference limit at 15 or 20 micrograms per litre. The Medical Journal of Australia recognises iron depletion at ferritin below 30. Research suggests that fatigue may persist until ferritin exceeds 100. A woman with a ferritin of 22 will receive a "normal" result at most labs, while her iron stores are depleted enough to impair energy, concentration, and dopamine synthesis.
Vitamin D. The standard laboratory threshold for deficiency is typically 50 nmol/L. A 2012 Australian study found that 73% of adults fell below 75 nmol/L, a level widely considered optimal by endocrinologists and vitamin D researchers. The ABS found that 23% of Australian adults are deficient below 50, rising to 49% in Victoria and the ACT during winter. A result of 55 is "normal." Whether it's optimal for your cognition, mood, and bone density is a different question.
TSH (thyroid stimulating hormone). Standard reference intervals typically run from 0.5 to 4.0 or 4.5 mIU/L. A TSH of 3.5 is technically normal. But research on subclinical hypothyroidism, which affects 4 to 20% of adults, suggests that symptoms can appear at levels well within the standard range. The ratio of subclinical to overt thyroid disease is 15 to 1. The standard interval catches the overt cases. The subclinical ones, which cause real symptoms, often pass through.
Vitamin B12. Standard laboratory lower limits are often set around 200 pg/mL. A review in American Family Physician found that approximately 50% of people with subclinical B12 deficiency had serum levels within the "normal" range. A broader analysis found that 12.5% of adults are insufficient below 300, but only 3.6% are flagged at the standard threshold below 200. The standard cutoff misses approximately three-quarters of insufficient cases.
What this means for someone who's never been tested
If you've never had a comprehensive blood test, this framework matters just as much as it does for someone who got a "normal" result and felt unconvinced. Because the question isn't whether your results will come back normal. For most people, most markers will. The question is what "normal" is actually measuring.
A blood test designed to catch disease will tell you whether you have one. That's valuable. It's also not the only question worth asking. Whether your biology is performing, whether your systems are working together efficiently, whether you're functioning at the level you used to, these are different questions that require different reference points.
This isn't a criticism of standard pathology. Standard pathology does what it was designed to do, and it does it well. The gap is one of purpose, not quality. A disease-detection panel and a performance assessment serve different purposes, use different reference points, and answer different questions.
How VitalYOU approaches this differently
VitalYOU's assessment uses performance-oriented reference points alongside standard intervals. When your doctor reviews your results, they're not just checking whether each marker falls inside the laboratory range. They're assessing where each result sits relative to the level associated with optimal function, and they're looking at how markers interact across systems.
A ferritin of 25 and a free T3 of 3.8 are both "in range." Together, with reported fatigue, afternoon crashes, and poor recovery, they tell a story that neither marker tells alone. The pattern is the diagnosis, not the individual number.
VitalYOU measures more than 80 biomarkers across six key biological systems: hormonal, metabolic, cardiovascular, inflammatory, hepatic, and renal. Your doctor reviews every result before your consultation. The report explains what each marker measures, where your result sits, and what that means in context, not just whether it's in range.
The reference interval is a useful tool. It's just not the only tool. And for the growing number of Australians who feel that something is off but have been told their results are fine, understanding the difference between "in range" and "performing well" is the first step toward a clearer picture.
A blood test is only as useful as the question it was designed to answer.
Disclosure
*A note from the VitalYOU clinical team: We believe in optimising your biology for peak vitality and in providing precision medicine tailored just for you. However, this article is for informational purposes and isn't a substitute for professional medical advice. Brain fog is usually a compound metabolic problem, but it's still important to rule out serious neurological conditions. If you are experiencing rapid or severe cognitive changes, please consult your GP.*
Sources
- 1.Jones GRD et al., *Clinical Biochemist Reviews* (RCPA/AACB), 2015
- 2.Jones GRD & Koetsier S, *Annals of Clinical Biochemistry*, 2017
- 3.Jones GRD et al., *Clinical Biochemist Reviews*, 2014 (ISO 15189)
- 4.Zhang et al., *Medical Journal of Australia*, 2024
- 5.Daly RM et al., *Clinical Endocrinology*, 2012
- 6.ABS National Health Measures Survey, 2011-12
- 7.Oh R, Brown DL, *American Family Physician*, 2003
- 8.Soppi ET, *Clinical Case Reports*, 2018



